EMILY YORK: Open Payments
NPI 1003570979 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 37 payments from 17 companies in 2025. Trend: 2023 $326 · 2024 $638 · 2025 $809
Food & beverage: $716Education: $93
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $206 |
| SEAGEN INC. | 1 | $93 |
| ABBVIE INC. | 4 | $82 |
| Janssen Biotech, Inc. | 3 | $48 |
| Celgene Corporation | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Genentech USA, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $40 |
| SERVIER PHARMACEUTICALS LLC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
Products named: KISQALI, SCEMBLIX, REBLOZYL, KEYTRUDA, XTANDI, Voranigo, EPKINLY, ERLEADA.
Industry payments across IN — which companies pay providers there.
